Evidence map›Paper›PMID 38700032›Full record

ArticleJournal of the American Heart Association2024

Impact of Society Guidelines on Trends in Use of Newer P2Y

Mohamed O Mohamed, Evangelos Kontopantelis, Mirvat Alasnag, Leila Abid, Amitava Banerjee, Andrew S P Sharp, Christos Bourantas, Alex Sirker, Nick Curzen, Mamas A Mamas

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mohamed O MohamedKeele Cardiovascular Research Group, Centre for Prognosis Research Keele University Stoke-on-Trent United Kingdom.ORCID 0000-0002-9678-5222
Evangelos KontopantelisDivision of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC) University of Manchester United Kingdom.ORCID 0000-0001-6450-5815
Mirvat AlasnagCardiac Center King Fahd Armed Forces Hospital Jeddah Saudi Arabia.ORCID 0000-0002-8714-0334
Leila AbidHedi Chaker University Hospital Sfax Tunisia.ORCID 0000-0001-7793-5240
Amitava BanerjeeInstitute of Health Informatics University College London London United Kingdom.ORCID 0000-0001-8741-3411
Andrew S P SharpDepartment of Cardiology University Hospitals Wales Cardiff United Kingdom.ORCID 0000-0002-9085-8881
Christos BourantasBarts Heart Centre St. Bartholomew's Hospital London United Kingdom.ORCID 0000-0001-5319-1064
Alex SirkerBarts Heart Centre St. Bartholomew's Hospital London United Kingdom.
Nick CurzenFaculty of Medicine University of Southampton United Kingdom.ORCID 0000-0001-9651-7829
Mamas A MamasKeele Cardiovascular Research Group, Centre for Prognosis Research Keele University Stoke-on-Trent United Kingdom.ORCID 0000-0001-9241-8890

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOver the past decade, major society guidelines have recommended the use of newer P2Y METHODS AND

resultsAll percutaneous coronary intervention procedures (n=534 210) for acute coronary syndrome in England and Wales (April 1, 2010, to March 31, 2022) were retrospectively analyzed, stratified by choice of preprocedural P2Y

conclusionsOver a 13-year-period, there has been a significant increase in use of newer P2Y

Indexed as

Acute Coronary SyndromeClopidogrelPercutaneous Coronary InterventionPractice Guidelines as TopicPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsTicagrelorAgedEnglandFemaleGuideline AdherenceHumansMaleMiddle AgedNon-ST Elevated Myocardial InfarctionPlatelet Aggregation InhibitorsClopidogrelPlatelet Aggregation InhibitorsPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsTicagreloracute coronary syndromenewer P2Y12 inhibitorsoutcomespercutaneous coronary interventiontrends

Identifiers

PMID38700032
PMCPMC11179911

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.